The E545K and E545A mutations in PIK3CA have not only been detected upon progression in advanced ALK‐positive NSCLC patients, but also in EGFR‐positive NSCLC patients [28, 29]. This evidence concerns the gene ALK and non-small cell lung carcinoma.